Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life - PubMed (original) (raw)
Randomized Controlled Trial
. 2008 Jun;138(6):1091-5.
doi: 10.1093/jn/138.6.1091.
Affiliations
- PMID: 18492839
- DOI: 10.1093/jn/138.6.1091
Free article
Randomized Controlled Trial
Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life
Sertac Arslanoglu et al. J Nutr. 2008 Jun.
Free article
Abstract
A mixture of neutral short-chain galactooligosaccharides (scGOS) and long-chain fructooligosaccharides (lcFOS) has been shown to reduce the incidence of atopic dermatitis (AD) and infectious episodes during the first 6 mo of life. This dual protection occurred through the intervention period. The present study evaluated if these protective effects were lasting beyond the intervention period. In a prospective, randomized, double-blind, placebo-controlled design, healthy term infants with a parental history of atopy were fed either a prebiotic-supplemented (8 g/L scGOS/lcFOS) or placebo-supplemented (8 g/L maltodextrin) hypoallergenic formula during the first 6 mo of life. Following this intervention period, blind follow-up continued until 2 y of life. Primary endpoints were cumulative incidence of allergic manifestations. Secondary endpoints were number of infectious episodes and growth. Of 152 participants, 134 infants (68 in placebo, 66 in intervention group) completed the follow-up. During this period, infants in the scGOS/lcFOS group had significantly lower incidence of allergic manifestations. Cumulative incidences for AD, recurrent wheezing, and allergic urticaria were higher in the placebo group, (27.9, 20.6, and 10.3%, respectively) than in the intervention group (13.6, 7.6, and 1.5%) (P < 0.05). Infants in the scGOS/lcFOS group had fewer episodes of physician-diagnosed overall and upper respiratory tract infections (P < 0.01), fever episodes (P < 0.00001), and fewer antibiotic prescriptions (P < 0.05). Growth was normal and similar in both groups. Early dietary intervention with oligosaccharide prebiotics has a protective effect against both allergic manifestations and infections. The observed dual protection lasting beyond the intervention period suggests that an immune modulating effect through the intestinal flora modification may be the principal mechanism of action.
Similar articles
- Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life.
Arslanoglu S, Moro GE, Boehm G, Wienz F, Stahl B, Bertino E. Arslanoglu S, et al. J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3 Suppl):49-59. J Biol Regul Homeost Agents. 2012. PMID: 23158515 Clinical Trial. - Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life.
Arslanoglu S, Moro GE, Boehm G. Arslanoglu S, et al. J Nutr. 2007 Nov;137(11):2420-4. doi: 10.1093/jn/137.11.2420. J Nutr. 2007. PMID: 17951479 Clinical Trial. - Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy.
Schouten B, Van Esch BC, Kormelink TG, Moro GE, Arslanoglu S, Boehm G, Knippels LM, Redegeld FA, Willemsen LE, Garssen J. Schouten B, et al. Pediatr Allergy Immunol. 2011 Aug;22(5):537-42. doi: 10.1111/j.1399-3038.2010.01132.x. Pediatr Allergy Immunol. 2011. PMID: 21771085 Clinical Trial. - Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S. Halken S. Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review. - Gastrointestinal Health and Immunity of Milk Formula Supplemented with a Prebiotic Mixture of Short-Chain Galacto-oligosaccharides and Long-Chain Fructo-Oligosaccharides (9:1) in Healthy Infants and Toddlers: A Systematic Review with Meta-Analysis.
Kadim M, Darma A, Kartjito MS, Dilantika C, Basrowi RW, Sungono V, Jo J. Kadim M, et al. Pediatr Gastroenterol Hepatol Nutr. 2025 Jan;28(1):1-18. doi: 10.5223/pghn.2025.28.1.1. Epub 2025 Jan 8. Pediatr Gastroenterol Hepatol Nutr. 2025. PMID: 39839466 Free PMC article. Review.
Cited by
- Pathogen-induced secretory diarrhea and its prevention.
Anand S, Mandal S, Patil P, Tomar SK. Anand S, et al. Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1721-1739. doi: 10.1007/s10096-016-2726-5. Epub 2016 Jul 29. Eur J Clin Microbiol Infect Dis. 2016. PMID: 27473379 Review. - Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial.
Luoto R, Ruuskanen O, Waris M, Kalliomäki M, Salminen S, Isolauri E. Luoto R, et al. J Allergy Clin Immunol. 2014 Feb;133(2):405-13. doi: 10.1016/j.jaci.2013.08.020. Epub 2013 Oct 13. J Allergy Clin Immunol. 2014. PMID: 24131826 Free PMC article. Clinical Trial. - Food allergy and atopic dermatitis: how are they connected?
Heratizadeh A, Wichmann K, Werfel T. Heratizadeh A, et al. Curr Allergy Asthma Rep. 2011 Aug;11(4):284-91. doi: 10.1007/s11882-011-0202-y. Curr Allergy Asthma Rep. 2011. PMID: 21614611 - The role of probiotics and prebiotics in inducing gut immunity.
Vieira AT, Teixeira MM, Martins FS. Vieira AT, et al. Front Immunol. 2013 Dec 12;4:445. doi: 10.3389/fimmu.2013.00445. Front Immunol. 2013. PMID: 24376446 Free PMC article. Review. - The role of the microbiome for human health: from basic science to clinical applications.
Mohajeri MH, Brummer RJM, Rastall RA, Weersma RK, Harmsen HJM, Faas M, Eggersdorfer M. Mohajeri MH, et al. Eur J Nutr. 2018 May;57(Suppl 1):1-14. doi: 10.1007/s00394-018-1703-4. Eur J Nutr. 2018. PMID: 29748817 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical